Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome - PubMed (original) (raw)

Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome

G M Shaw et al. Science. 1984.

Abstract

The human T-cell leukemia (lymphotropic) virus type III (HTLV-III) appears to be central to the causation of the acquired immune deficiency syndrome (AIDS). Two full-length integrated proviral DNA forms of HTLV-III have now been cloned and analyzed, and DNA sequences of the virus in cell lines and fresh tissues from patients with AIDS or AIDS-related complex (ARC) have been characterized. The results revealed that (i) HTLV-III is an exogenous human retrovirus, approximately 10 kilobases in length, that lacks nucleic acid sequences derived from normal human DNA; (ii) HTLV-III, unlike HTLV types I and II, shows substantial diversity in its genomic restriction enzyme cleavage pattern; (iii) HTLV-III persists in substantial amounts in cells as unintegrated linear DNA, an uncommon property that has been linked to the cytopathic effects of certain animal retroviruses; and (iv) HTLV-III viral DNA can be detected in low levels in fresh (primary) lymphoid tissue of a minority of patients with AIDS or ARC but appears not to be present in Kaposi's sarcoma tissue. These findings have important implications concerning the biological properties of HTLV-III and the pathophysiology of AIDS and Kaposi's sarcoma.

PubMed Disclaimer

Cited by

Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.
Kannagi M, Kiyotaki M, Desrosiers RC, Reimann KA, King NW, Waldron LM, Letvin NL. Kannagi M, et al. J Clin Invest. 1986 Nov;78(5):1229-36. doi: 10.1172/JCI112706. J Clin Invest. 1986. PMID: 3771794 Free PMC article.
TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes.
Harrich D, Garcia J, Mitsuyasu R, Gaynor R. Harrich D, et al. EMBO J. 1990 Dec;9(13):4417-23. doi: 10.1002/j.1460-2075.1990.tb07892.x. EMBO J. 1990. PMID: 2124973 Free PMC article.
Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies.
Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ. Kwok S, et al. Nucleic Acids Res. 1990 Feb 25;18(4):999-1005. doi: 10.1093/nar/18.4.999. Nucleic Acids Res. 1990. PMID: 2179874 Free PMC article.
Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.
Carroll R, Peterlin BM, Derse D. Carroll R, et al. J Virol. 1992 Apr;66(4):2000-7. doi: 10.1128/JVI.66.4.2000-2007.1992. J Virol. 1992. PMID: 1312617 Free PMC article.
Neoplasia in AIDS.
Krown SE. Krown SE. Bull N Y Acad Med. 1987 Sep;63(7):679-91. Bull N Y Acad Med. 1987. PMID: 3315068 Free PMC article. Review. No abstract available.

Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome - PubMed (original) (raw)